• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4840107)   Today's Articles (10964)
For: Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B 2022;12:3049-3062. [PMID: 35865092 PMCID: PMC9293739 DOI: 10.1016/j.apsb.2022.02.002] [Citation(s) in RCA: 620] [Impact Index Per Article: 206.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 02/03/2022] [Accepted: 02/06/2022] [Indexed: 12/14/2022]  Open
Number Cited by Other Article(s)
101
Kyro GW, Martin MT, Watt ED, Batista VS. CardioGenAI: a machine learning-based framework for re-engineering drugs for reduced hERG liability. J Cheminform 2025;17:30. [PMID: 40045386 PMCID: PMC11881490 DOI: 10.1186/s13321-025-00976-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2024] [Accepted: 02/21/2025] [Indexed: 03/09/2025]  Open
102
Czechowicz P, Więch-Walów A, Sławski J, Collawn JF, Bartoszewski R. Old drugs, new challenges: reassigning drugs for cancer therapies. Cell Mol Biol Lett 2025;30:27. [PMID: 40038587 PMCID: PMC11881393 DOI: 10.1186/s11658-025-00710-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2024] [Accepted: 02/24/2025] [Indexed: 03/06/2025]  Open
103
Zhang PZ, Ballard J, Esquivel Fagiani F, Smith D, Gibson C, Yu X. Large-Scale Compartmental Model-Based Study of Preclinical Pharmacokinetic Data and Its Impact on Compound Triaging in Drug Discovery. Mol Pharm 2025;22:1230-1240. [PMID: 39960135 DOI: 10.1021/acs.molpharmaceut.4c00813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/04/2025]
104
Akbari M. Transforming Drug Discovery with Miniaturized Predictive Tissue Models. MICROMACHINES 2025;16:299. [PMID: 40141910 PMCID: PMC11944397 DOI: 10.3390/mi16030299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/21/2025] [Accepted: 02/25/2025] [Indexed: 03/28/2025]
105
Rasul HO, Ghafour DD, Aziz BK, Hassan BA, Rashid TA, Kivrak A. Decoding Drug Discovery: Exploring A-to-Z In Silico Methods for Beginners. Appl Biochem Biotechnol 2025;197:1453-1503. [PMID: 39630336 DOI: 10.1007/s12010-024-05110-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/19/2024] [Indexed: 03/29/2025]
106
Ali S, Shaikh S, Ahmad K, Choi I. Identification of active compounds as novel dipeptidyl peptidase-4 inhibitors through machine learning and structure-based molecular docking simulations. J Biomol Struct Dyn 2025;43:1611-1620. [PMID: 38100571 DOI: 10.1080/07391102.2023.2292299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 11/23/2023] [Indexed: 12/17/2023]
107
Yousefian M, Hashemi M, Eskandarpour V, Zarghi A, Hadizadeh F, Ghodsi R. New indolin-2-ones, possessing sunitinib scaffold as HDAC inhibitors and anti-cancer agents with potential VEGFR inhibition activity; design, synthesis and biological evaluation. Bioorg Chem 2025;156:108231. [PMID: 39904079 DOI: 10.1016/j.bioorg.2025.108231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2024] [Revised: 01/23/2025] [Accepted: 01/29/2025] [Indexed: 02/06/2025]
108
Chowdhury R, Bhuia S, Rakib AI, Al Hasan S, Shill MC, El-Nashar HAS, El-Shazly M, Islam MT. Gigantol, a promising natural drug for inflammation: a literature review and computational based study. Nat Prod Res 2025;39:1241-1257. [PMID: 38623737 DOI: 10.1080/14786419.2024.2340042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 03/18/2024] [Accepted: 03/26/2024] [Indexed: 04/17/2024]
109
Avolio E, Bassani B, Campanile M, Mohammed KA, Muti P, Bruno A, Spinetti G, Madeddu P. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing? Pharmacol Rev 2025;77:100033. [PMID: 40148035 DOI: 10.1016/j.pharmr.2024.100033] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2024] [Accepted: 12/17/2024] [Indexed: 03/29/2025]  Open
110
Guan H, Chen J, Yin H, Feng X, Liu C, Liu S, Li J, Li J, Cao Y, Ma C. A UHPLC-MS/MS Method Reveals the Pharmacokinetics of Deacetyl Asperulosidic Acid Methyl Ester in Rats. Biomed Chromatogr 2025;39:e70001. [PMID: 39917783 DOI: 10.1002/bmc.70001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2024] [Revised: 12/08/2024] [Accepted: 01/03/2025] [Indexed: 05/08/2025]
111
Wu Y, Tang K, Wang C, Song H, Zhou F, Guo Y. Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features. Acta Pharm Sin B 2025;15:1344-1358. [PMID: 40370539 PMCID: PMC12069252 DOI: 10.1016/j.apsb.2025.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 09/13/2024] [Accepted: 09/14/2024] [Indexed: 05/16/2025]  Open
112
Lin JZ, Kominia M, Doorduin J, de Vries EFJ. PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model. Nucl Med Biol 2025;142-143:108985. [PMID: 39662136 DOI: 10.1016/j.nucmedbio.2024.108985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 11/22/2024] [Accepted: 11/29/2024] [Indexed: 12/13/2024]
113
Truong L, Bieberich AA, Fatig RO, Rajwa B, Simonich MT, Tanguay RL. Accelerating antiviral drug discovery: early hazard detection with a dual zebrafish and cell culture screen of a 403 compound library. Arch Toxicol 2025;99:1029-1041. [PMID: 39730949 PMCID: PMC11821682 DOI: 10.1007/s00204-024-03948-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Accepted: 12/17/2024] [Indexed: 12/29/2024]
114
Lomash RM, Dehdashti J, Shchelochkov OA, Chandler RJ, Li L, Manoli I, Sloan JL, Terse P, Xu X, Saade D, Stan R, Brooks PJ, Lo DC, Bönnemann CG, Venditti CP, Pariser AR, Ottinger EA. Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program. Hum Gene Ther 2025;36:653-662. [PMID: 39976996 PMCID: PMC11971537 DOI: 10.1089/hum.2024.230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2024] [Accepted: 12/24/2024] [Indexed: 03/14/2025]  Open
115
Menestrina L, Parrondo-Pizarro R, Gómez I, Garcia-Serna R, Boyer S, Mestres J. Refined ADME Profiles for ATC Drug Classes. Pharmaceutics 2025;17:308. [PMID: 40142973 PMCID: PMC11944659 DOI: 10.3390/pharmaceutics17030308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Revised: 02/18/2025] [Accepted: 02/26/2025] [Indexed: 03/28/2025]  Open
116
Thakur GS, Gupta AK, Pal D, Vaishnav Y, Kumar N, Annadurai S, Jain SK. Designing novel cabozantinib analogues as p-glycoprotein inhibitors to target cancer cell resistance using molecular docking study, ADMET screening, bioisosteric approach, and molecular dynamics simulations. Front Chem 2025;13:1543075. [PMID: 40084274 PMCID: PMC11903459 DOI: 10.3389/fchem.2025.1543075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2024] [Accepted: 02/04/2025] [Indexed: 03/16/2025]  Open
117
Yang Q, Yao L, Chen Z, Wang X, Jia F, Pang G, Huang M, Li J, Fan L. Exploring a new paradigm for serum-accessible component rules of natural medicines using machine learning and development and validation of a direct predictive model. Int J Pharm 2025;671:125207. [PMID: 39826781 DOI: 10.1016/j.ijpharm.2025.125207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2024] [Revised: 12/30/2024] [Accepted: 01/08/2025] [Indexed: 01/22/2025]
118
Soundara Pandi SP, Winter H, Smith MR, Harkin K, Bojdo J. Preclinical Retinal Disease Models: Applications in Drug Development and Translational Research. Pharmaceuticals (Basel) 2025;18:293. [PMID: 40143072 PMCID: PMC11944893 DOI: 10.3390/ph18030293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2025] [Revised: 02/10/2025] [Accepted: 02/18/2025] [Indexed: 03/28/2025]  Open
119
Kovari D, Male L, Roper KA, Mang CP, Kunz O, Cox LR. Short Scalable Route to Bis-morpholine Spiroacetals and Oxazepane Analogues: Useful 3D-Scaffolds for Compound Library Assembly. J Org Chem 2025;90:2652-2661. [PMID: 39927818 PMCID: PMC11852203 DOI: 10.1021/acs.joc.4c02690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2024] [Revised: 01/19/2025] [Accepted: 01/23/2025] [Indexed: 02/11/2025]
120
Han W, Zhou Q, Wang MW. Current challenges and future perspectives of drug discovery in China. Expert Opin Drug Discov 2025:1-10. [PMID: 39953852 DOI: 10.1080/17460441.2025.2468290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 02/03/2025] [Accepted: 02/13/2025] [Indexed: 02/17/2025]
121
Wang L, Gao Y, Chen Y, Tang Z, Lin X, Bai M, Cao P, Liu K. Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein-Ligand Binding Free Energy Calculations. Int J Mol Sci 2025;26:1527. [PMID: 40003993 PMCID: PMC11854949 DOI: 10.3390/ijms26041527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2024] [Revised: 01/30/2025] [Accepted: 02/08/2025] [Indexed: 02/27/2025]  Open
122
Wang N, Dong J, Ouyang D. AI-directed formulation strategy design initiates rational drug development. J Control Release 2025;378:619-636. [PMID: 39719215 DOI: 10.1016/j.jconrel.2024.12.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2024] [Revised: 11/27/2024] [Accepted: 12/18/2024] [Indexed: 12/26/2024]
123
Alanazi M, Alanazi J, Alharby TN, Huwaimel B. Correlation of rivaroxaban solubility in mixed solvents for optimization of solubility using machine learning analysis and validation. Sci Rep 2025;15:4725. [PMID: 39922955 PMCID: PMC11807219 DOI: 10.1038/s41598-025-89093-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Accepted: 02/03/2025] [Indexed: 02/10/2025]  Open
124
Cook RL, Martelly W, Agu CV, Gushgari LR, Moreno S, Kesiraju S, Mohan M, Takulapalli B. An approach to produce thousands of single-chain antibody variants on a SPR biosensor chip for measuring target binding kinetics and for deep characterization of antibody paratopes. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2025:2025.01.11.632576. [PMID: 39868233 PMCID: PMC11760398 DOI: 10.1101/2025.01.11.632576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2025]
125
Ruankham W, Pingaew R, Prachayasittikul V, Worachartcheewan A, Sathuphong S, Apiraksattayakul S, Tantimongcolwat T, Prachayasittikul V, Prachayasittikul S, Phopin K. Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: in vitro biological and in silico pharmacokinetic assessments. RSC Adv 2025;15:4281-4295. [PMID: 39931414 PMCID: PMC11809491 DOI: 10.1039/d4ra04941a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Accepted: 01/14/2025] [Indexed: 02/13/2025]  Open
126
Das SK, Mishra R, Samanta A, Shil D, Roy SD. Deep learning: A game changer in drug design and development. ADVANCES IN PHARMACOLOGY (SAN DIEGO, CALIF.) 2025;103:101-120. [PMID: 40175037 DOI: 10.1016/bs.apha.2025.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/04/2025]
127
Zhang C, Dong YX, Gao LX, Gan S, Gao W, Li J, Xiang DJ, Wang X, Zhou YB, Wang WL. 6H-Indolo-[2,3-b]-quinoxaline derivatives as promising bifunctional SHP1 inhibitors. Org Biomol Chem 2025;23:1394-1405. [PMID: 39744882 DOI: 10.1039/d4ob01492h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2025]
128
Namba S, Li C, Yuyama Otani N, Yamanishi Y. SSL-VQ: vector-quantized variational autoencoders for semi-supervised prediction of therapeutic targets across diverse diseases. Bioinformatics 2025;41:btaf039. [PMID: 39880378 PMCID: PMC11842052 DOI: 10.1093/bioinformatics/btaf039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2024] [Revised: 01/14/2025] [Accepted: 01/25/2025] [Indexed: 01/31/2025]  Open
129
Wei X, Li M, Tu Y, Wang L. ROC-guided virtual screening, molecular dynamics simulation, and bioactivity validation assessment Z195914464 as a 3CL Mpro inhibitor. Biophys Chem 2025;317:107357. [PMID: 39612624 DOI: 10.1016/j.bpc.2024.107357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Revised: 10/30/2024] [Accepted: 11/20/2024] [Indexed: 12/01/2024]
130
Abdelrady YA, Thabet HS, Sayed AM. The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing. Pharmacol Rep 2025;77:1-20. [PMID: 39432183 DOI: 10.1007/s43440-024-00662-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Revised: 09/30/2024] [Accepted: 10/01/2024] [Indexed: 10/22/2024]
131
Disha IJ, Hasan R, Bhuia S, Ansari SA, Ansari IA, Islam MT. Anxiolytic Efficacy of Indirubin: In Vivo Approach Along with Receptor Binding Profiling and Molecular Interaction with GABAergic Pathways. ChemistryOpen 2025;14:e202400290. [PMID: 39460441 PMCID: PMC11808267 DOI: 10.1002/open.202400290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 09/03/2024] [Indexed: 10/28/2024]  Open
132
Boonsom S, Chamnansil P, Boonseng S, Srisongkram T. ToxSTK: A multi-target toxicity assessment utilizing molecular structure and stacking ensemble learning. Comput Biol Med 2025;185:109480. [PMID: 39644580 DOI: 10.1016/j.compbiomed.2024.109480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2024] [Revised: 11/04/2024] [Accepted: 11/25/2024] [Indexed: 12/09/2024]
133
Li T, Wan Z, Wang Q, Qiao F, Pan G, Zhao C, Zhu Y, Zhou H, Tan Y, Zhou Z, Zhang D. Utilizing Tissues Self-Assembled in Fiber Optic-Based "Chinese Guzheng Strings" for Contractility Sensing and Drug Efficacy Evaluation: A Practical Approach. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2025;21:e2406144. [PMID: 39822158 DOI: 10.1002/smll.202406144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2024] [Revised: 12/25/2024] [Indexed: 01/19/2025]
134
Woodward DJ, Thorp JG, Middeldorp CM, Akóṣílè W, Derks EM, Gerring ZF. Leveraging pleiotropy for the improved treatment of psychiatric disorders. Mol Psychiatry 2025;30:705-721. [PMID: 39390223 PMCID: PMC11746150 DOI: 10.1038/s41380-024-02771-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Revised: 09/23/2024] [Accepted: 09/25/2024] [Indexed: 10/12/2024]
135
Krendl FJ, Primavesi F, Oberhuber R, Neureiter D, Ocker M, Bekric D, Kiesslich T, Mayr C. The importance of preclinical models for cholangiocarcinoma drug discovery. Expert Opin Drug Discov 2025;20:205-216. [PMID: 39840603 DOI: 10.1080/17460441.2025.2457637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Revised: 01/09/2025] [Accepted: 01/20/2025] [Indexed: 01/23/2025]
136
Inal-Gültekin G, Çetin Z, Mangır N. Exploring Drug Repurposing for Interstitial Cystitis/Bladder Pain Syndrome: Defining Novel Therapeutic Targets. Neurourol Urodyn 2025;44:496-503. [PMID: 39723619 DOI: 10.1002/nau.25651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2024] [Accepted: 12/04/2024] [Indexed: 12/28/2024]
137
van Bergen W, Nederstigt AE, Heck AJR, Baggelaar MP. Site-Specific Competitive Kinase Inhibitor Target Profiling Using Phosphonate Affinity Tags. Mol Cell Proteomics 2025;24:100906. [PMID: 39826875 PMCID: PMC11889359 DOI: 10.1016/j.mcpro.2025.100906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Revised: 01/10/2025] [Accepted: 01/12/2025] [Indexed: 01/22/2025]  Open
138
Kim Y, Kang M, Mamo MG, Adisasmita M, Huch M, Choi D. Liver organoids: Current advances and future applications for hepatology. Clin Mol Hepatol 2025;31:S327-S348. [PMID: 39722609 PMCID: PMC11925438 DOI: 10.3350/cmh.2024.1040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Revised: 12/13/2024] [Accepted: 12/24/2024] [Indexed: 12/28/2024]  Open
139
Debnath A, Singh RK, Mazumder R, Mazumder A, Srivastava S, Chaudhary H, Mangal S, Sanchitra J, Tyagi PK, Kumar Singh S, Singh AK. Quest for discovering novel CDK12 inhibitor. J Recept Signal Transduct Res 2025;45:1-21. [PMID: 39697035 DOI: 10.1080/10799893.2024.2441185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 12/04/2024] [Accepted: 12/06/2024] [Indexed: 12/20/2024]
140
Masand VH, Patil MK, Al-Hussain SA, Samad A, Rastija V, Jawarkar RD, Masand GS, Gawali RG, Zaki MEA. Analyzing Oxygen Atom Distribution in FDA-Approved Drugs to Enhance Drug Discovery Strategies. Chem Biol Drug Des 2025;105:e70060. [PMID: 39912316 DOI: 10.1111/cbdd.70060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Revised: 12/26/2024] [Accepted: 01/22/2025] [Indexed: 02/07/2025]
141
McGreevy O, Bosakhar M, Gilbert T, Quinn M, Fenwick S, Malik H, Goldring C, Randle L. The importance of preclinical models in cholangiocarcinoma. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025;51:108304. [PMID: 38653585 DOI: 10.1016/j.ejso.2024.108304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Accepted: 03/23/2024] [Indexed: 04/25/2024]
142
Orszulak L, Włodarczyk P, Hachuła B, Lamrani T, Jurkiewicz K, Tarnacka M, Hreczka M, Kamiński K, Kamińska E. Inhibition of naproxen crystallization by polymers: The role of topology and chain length of polyvinylpyrrolidone macromolecules. Eur J Pharm Biopharm 2025;207:114581. [PMID: 39608423 DOI: 10.1016/j.ejpb.2024.114581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2024] [Revised: 11/07/2024] [Accepted: 11/13/2024] [Indexed: 11/30/2024]
143
Ireland D, Rabeler C, Rao S, Richardson RJ, Collins EMS. Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians. PLoS One 2025;20:e0315394. [PMID: 39883642 PMCID: PMC11781733 DOI: 10.1371/journal.pone.0315394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2024] [Accepted: 11/25/2024] [Indexed: 02/01/2025]  Open
144
Unlocking drug modes of action with multi-dimensional high-throughput metabolic profiling. Nat Biotechnol 2025:10.1038/s41587-024-02525-4. [PMID: 39875673 DOI: 10.1038/s41587-024-02525-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2025]
145
Testa M, Gaggianesi M, D’Accardo C, Porcelli G, Turdo A, Di Marco C, Patella B, Di Franco S, Modica C, Di Bella S, Lopresti F, Stassi G, La Carrubba V, Todaro M. A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening. Int J Mol Sci 2025;26:1028. [PMID: 39940796 PMCID: PMC11816644 DOI: 10.3390/ijms26031028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Revised: 01/20/2025] [Accepted: 01/23/2025] [Indexed: 02/16/2025]  Open
146
Srirangan P, Sabina EP. Protective effects of herbal compounds against cyclophosphamide-induced organ toxicity: a pathway-centered approach. Drug Chem Toxicol 2025:1-43. [PMID: 39847469 DOI: 10.1080/01480545.2025.2455442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2024] [Revised: 12/24/2024] [Accepted: 01/14/2025] [Indexed: 01/25/2025]
147
Bois A, Grandela C, Gallant J, Mummery C, Menasché P. Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction. NPJ Regen Med 2025;10:6. [PMID: 39843488 PMCID: PMC11754855 DOI: 10.1038/s41536-025-00394-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Accepted: 01/13/2025] [Indexed: 01/24/2025]  Open
148
Ghazi Vakili M, Gorgulla C, Snider J, Nigam A, Bezrukov D, Varoli D, Aliper A, Polykovsky D, Padmanabha Das KM, Cox Iii H, Lyakisheva A, Hosseini Mansob A, Yao Z, Bitar L, Tahoulas D, Čerina D, Radchenko E, Ding X, Liu J, Meng F, Ren F, Cao Y, Stagljar I, Aspuru-Guzik A, Zhavoronkov A. Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors. Nat Biotechnol 2025:10.1038/s41587-024-02526-3. [PMID: 39843581 DOI: 10.1038/s41587-024-02526-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Accepted: 12/06/2024] [Indexed: 01/24/2025]
149
Réda C, Vie JJ, Wolkenhauer O. Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing. Sci Rep 2025;15:2711. [PMID: 39837888 PMCID: PMC11751339 DOI: 10.1038/s41598-025-85927-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Accepted: 01/07/2025] [Indexed: 01/23/2025]  Open
150
Ana G, Malebari AM, Noorani S, Fayne D, O’Boyle NM, Zisterer DM, Pimentel EF, Endringer DC, Meegan MJ. (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer. Pharmaceuticals (Basel) 2025;18:118. [PMID: 39861179 PMCID: PMC11769294 DOI: 10.3390/ph18010118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2024] [Revised: 12/31/2024] [Accepted: 01/02/2025] [Indexed: 01/27/2025]  Open
PrevPage 3 of 13 123451213Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA